These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 92892)
21. [Alpha1-fetoprotein: physiology, pathology and diagnosis especially in childhood (author's transl)]. Knöpfle G; Becker M; Rotthauwe HW Klin Padiatr; 1977 Jul; 189(4):207-26. PubMed ID: 70546 [TBL] [Abstract][Full Text] [Related]
22. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study. Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS Tumori; 2014; 100(5):536-40. PubMed ID: 25343549 [TBL] [Abstract][Full Text] [Related]
23. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma. Johnson PJ; Melia WM; Palmer MK; Portmann B; Williams R Br J Cancer; 1981 Oct; 44(4):502-5. PubMed ID: 6170301 [TBL] [Abstract][Full Text] [Related]
24. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576 [TBL] [Abstract][Full Text] [Related]
25. Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma? Koh T; Taniguchi H; Katoh H; Kunishima S; Yamaguchi A; Yamagishi H Hepatogastroenterology; 2002; 49(48):1615-8. PubMed ID: 12397748 [TBL] [Abstract][Full Text] [Related]
27. Predicting the posttransplant prognosis of patients with hepatocellular carcinoma: what lies beneath alpha-fetoprotein? Giannini EG; Savarino V Liver Transpl; 2013 Oct; 19(10):1166-7. PubMed ID: 23929508 [No Abstract] [Full Text] [Related]
28. Sex steroid binding patterns in primary biliary cirrhosis complicated by hepatocellular carcinoma. Iqbal MJ; Wilkinson ML; Williams R Br Med J (Clin Res Ed); 1984 Aug; 289(6443):459-60. PubMed ID: 6205716 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients. Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228 [TBL] [Abstract][Full Text] [Related]
30. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status. Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531 [TBL] [Abstract][Full Text] [Related]
31. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients. Gani RA; Suryamin M; Hasan I; Lesmana CR; Sanityoso A Acta Med Indones; 2015 Jul; 47(3):216-22. PubMed ID: 26586387 [TBL] [Abstract][Full Text] [Related]
32. Elevated alpha-fetoprotein levels in hepatocellular carcinoma. Yao FY Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766 [No Abstract] [Full Text] [Related]
33. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Taketa K; Sekiya C; Namiki M; Akamatsu K; Ohta Y; Endo Y; Kosaka K Gastroenterology; 1990 Aug; 99(2):508-18. PubMed ID: 1694805 [TBL] [Abstract][Full Text] [Related]
35. α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theory. Lai Q; Lerut J; Liver Transpl; 2014 Oct; 20(10):1283. PubMed ID: 25060782 [No Abstract] [Full Text] [Related]
36. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use. Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F; Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129 [TBL] [Abstract][Full Text] [Related]
37. [Ataxia-telangiectasia syndrome. Clinical and diagnostic aspects]. Diaconu G; Grigore I; Moisă SM; Burlea M Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):386-90. PubMed ID: 17983173 [TBL] [Abstract][Full Text] [Related]
38. Non-hodgkin B-cell lymphoma of the ovary in a child with Ataxia-telangiectasia. Danby CS; Allen L; Moharir MD; Weitzman S; Dumont T J Pediatr Adolesc Gynecol; 2013 Apr; 26(2):e43-5. PubMed ID: 23312583 [TBL] [Abstract][Full Text] [Related]
39. Ataxia-telangiectasia. X,14 translocation, progressive deterioration of lymphocyte numbers and function, and abnormal in vitro immunoglobulin production. Beatty DW; Arens LJ; Nelson MM S Afr Med J; 1986 Jan; 69(2):115-8. PubMed ID: 2417340 [TBL] [Abstract][Full Text] [Related]
40. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation]. Barbare JC; Ballet F; Petit J; Poupon R; Darnis F Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]